Giuseppe Mele
14PUBLICATIONS
55CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (14)
Sort by Publication Date:
|Jun 27, 2025
Correction: Sgherza et al. Efficacy and Safety of Isatuximab, Carfilzomib, and Dexamethasone (IsaKd) in Multiple Myeloma Patients at the First Relapse After Autologous Stem Cell Transplantation and Lenalidomide Maintenance: Results from the Multicenter, Real-Life AENEID Study. Pharmaceuticals 2025, 18, 595.Nicola Sgherza, Olga Battisti, Paola Curci
|Apr 26, 2025
Efficacy and Safety of Isatuximab, Carfilzomib, and Dexamethasone (IsaKd) in Multiple Myeloma Patients at the First Relapse After Autologous Stem Cell Transplantation and Lenalidomide Maintenance: Results from the Multicenter, Real-Life AENEID Study.Nicola Sgherza, Olga Battisti, Paola Curci
|Feb 13, 2025
Overview of 1q abnormalities in multiple myeloma: scientific opinions from Italian experts.Mattia D'Agostino, Marina Martello, Lorenzo De Paoli
|Feb 03, 2025
Efficacy and Prognostic Indicators of Isatuximab, Pomalidomide, and Dexamethasone (IsaPd) in Daratumumab-Refractory Multiple Myeloma Patients: A Multicenter Real-World Study.Enrica Antonia Martino, Daniele Derudas, Elena Rossi
|Oct 26, 2024
Strengths and Weaknesses of Different Therapeutic Strategies for the Treatment of Patients with Multiple Myeloma Who Progress After the Frontline Use of Lenalidomide: A Narrative Review.Giuseppe Mele, Nicola Sgherza, Domenico Pastore
Pageof 3
Frequent Collaborators
5 joint publications
Roberta Della Pepa
4 joint publications
Pellegrino Musto
4 joint publications
Salvatore Palmieri
4 joint publications
Francesca Fazio
3 joint publications
Massimo Offidani
3 joint publications
Roberto Ria
3 joint publications
Nicola Sgherza
3 joint publications
Cirino Botta
3 joint publications
Iolanda Donatella Vincelli
3 joint publications
Daniele Derudas
